Results

Total Results: 1,292 records

Showing results for "how to do a case study".

1241. PULMONARY with "Discussions" in Exec Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
      January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … or may hold potential to diagnose, treat, or otherwise manage a particular condition or to improve … on topics and issuing topic drafts to a small group of various experts (selected topic by topic) to … Copayments vary according to the terms of a patient’s benefits. … limitations of the new therapy and how it affects their care.

1242. #06 Developmental Delays ADHD, and Autism (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - and conclusions in this document are those of the authors, who are responsible for its content, and do … or may hold potential to diagnose, treat, or otherwise manage a particular condition or to improve … a national Healthcare Horizon Scanning System to generate information to inform comparative-effectiveness … on topics and issuing topic drafts to a small group of various experts (selected topic by topic) to … lack of progress in basic understanding of these disorders and how to diagnose and treat them.

1243. Autism-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
      August 01, 2014 - was observed and how stable that effect is likely to be in the face of future research. … ge /c om m un ic at io n sk il ls , al th ou gh th e sp ec ifi c do m ai n of im … er ap y; n R C T = n on ra nd om iz ed c on tr ol le d tr ia l; R C T = r an do … to how interventions are described and implemented. … It is also unclear how similar groups of children would respond to differing levels of intervention

1244. CARDIOVASCULAR (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
      December 01, 2014 - and conclusions in this document are those of the authors, who are responsible for its content, and do … be a major barrier to acceptance. … availability of lipid-lowering pharmacotherapies used in the general population, many patients with HoFH do … three publications: a review article and two case reports. … Experts’ opinions differed somewhat about how much this intervention would disrupt health care delivery

1245. Arthritis-Knee-Physical-Therapy Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
      November 01, 2012 - Do harms differ by the duration of the treatment and time of followup? … Tables A and C show how many studies examined each outcome, estimated effect sizes, and our level of … Evidence from a single study was inconclusive for how racial differences affect treatment outcomes of … Average scores do not reveal how many or which types of patients develop disability or experience clinically … Average scores do not reveal how many or which patients develop disability or experience clinically

1246. #06 Developmental Delays ADHD, and Autism (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
      January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … regional research centers), and uncertainty about how it could really affect health outcomes because … Q sensor (a device to measure skin’s conductivity) can detect how well children with autism can recognize … research centers), and uncertainty about how it could really affect health outcomes because of its … Regarding how well this intervention could address the unmet need to accurately diagnose ASD and distinguish

1247. Obesity (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
      December 01, 2014 - and conclusions in this document are those of the authors, who are responsible for its content, and do … from the U.S. market because of concerns about safety and efficacy, which might negatively affect how … nonsurgical option for patients who do not wish to undergo bariatric surgery. … Several experts commented that patients would require initial training on how to properly self-inject … Other than initial training on how to use the injection pen, there is no reason to anticipate disruption

1248. Kidney-Stones-Draft-Appendi-C (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
      January 01, 2024 - achieve a urine volume equal to or greater than 2 L a day; All patients received water that was not … with pill counts but authors do not report actual levels of adherence Passage of new stones NR Appearance … Less than half of recurrences were symptomatic, but authors do not report specific numbers At 3 years … with pill counts but authors do not report actual levels of adherence Passage of new stones NR Appearance … done to consider the 6 subjects who left for AEs as treatment failures; Unclear how the other 17 subjects

1249. VTE Surveillance Assessment_49_low_SPI (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
      December 01, 2012 - i.e., Low, Medium, and High) for updating any given CER is based on the following two criteria: • How … • How out of date are conclusions (e.g., consideration of magnitude/direction of changes in estimates … We could not determine if this means that there is a lack of effect versus a lack of power to show … How quickly do systematic reviews go out of date? A survival analysis. … We could not determine if this means that there is a lack of effect versus a lack of power to show that

1250. Chicago-Area DEcIDE Center (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
      May 01, 2009 - depressive episodes, antidepressants do not appear to be effective in bipolar disorder.25 Hence, we … How future research efforts are organized, funded, and conducted are crucial issues. … Further, existing systems of coding (e.g., ICD-9) do not capture a variety of important nuances of clinical … those that do not. … 5 on a 1 to 5 scale

1251. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
      December 05, 2013 - and conclusions in this document are those of the authors, who are responsible for its content, and do … the payers listing policies for MSCs for OA consider the therapy investigational at this time and do … device depends on how much it has been manipulated after collection. … (IND), investigational device exemption (IDE), or new biologic, depending on how FDA categorizes the … not responding to conservative therapy and who do not want to undergo knee replacement.

1252. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
      January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … a Web site to order the product, at a cost of roughly $485 for three vials, plus shipping. 4 Patients … upon which to base a medical treatment. … Experts with a clinical perspective believe that this therapy has a very high potential to disrupt … Experts’ opinions were divided in assessment of how TSO might affect the per-patient costs of treating

1253. S66 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
      October 01, 2007 - In routine clinical practice, how- ever, adherence to chronic therapy is often suboptimal.15–17 Because … DMARD; and (2) time to switching to a different DMARD regimen. … therapies resulted in a switch to a different DMARD regimen. … to a different DMARD regimen (Table 2). … Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis

1254. Total Worker Health® (TWH) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
      April 01, 2016 - Investigators should lay out a framework for how the integrated intervention addressed both OSH and … to a particular population of workers. … groups of workers or work settings might help clarify not only the SOE for interventions but also how … In terms of outcomes, future studies should do a better job of measuring safety-related outcomes to … Finally, we urge investigators to plan ahead for how to handle differences between worker groups at

1255. Diabetes Mellitus (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
      January 01, 2015 - and conclusions in this document are those of the authors, who are responsible for its content, and do … Many patients with T2DM do not meet treatment goals and require additional therapy with one of two … the World Health Organization, people with diabetes who do not receive appropriate eye care have a … Researchers estimate that two-thirds of diabetic patients do not achieve adequate glycemic control … inform the sponsors of APDS IDE studies on how to support a PMA for “single patient use in the home

1256. Peripheral-Artery-Disease-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
      May 01, 2013 - Decisions about whether to revascularize and how to revascularize patients with PAD depend on a number … Do the safety concerns vary by subgroup (age, sex, race, risk factors, comorbidities, anatomic location … In adults with CLI due to PAD: a. … a small effect, 0.5 equates to a medium effect, 0.8 equates to a large effect, and effects larger than … There do not appear to be significant differences in mortality or limb outcomes between endovascular

1257. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
      January 01, 2012 - According to the Epilepsy Foundation, about 20% of patients with epilepsy do not respond to available … However, experts were divided on how likely clinicians would be to offer the therapy. … access to treatment for patients who do not live in close proximity to a hospital. … In terms of patient acceptance, a health systems expert questioned, “How does it affect speech? … Now all it has to do is convince the world they're necessary. [internet].

1258. Chronic-Kidney-Disease-Anemia-2011 Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
      January 01, 2011 - predict a response to IV iron treatment. … ) to predict a response to IV iron treatment … data are sufficient and reliable, decision analysis could be used to assess how employing combinations … how using combinations of different markers to guide iron management strategies might influence … all currently available laboratory biomarkers of iron status (either newer or classical markers) do

1259. Insomnia Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
      December 01, 2015 - change how patients think about sleep by identifying, challenging, and replacing dysfunctional beliefs … se b ut n ot 5 m g do se a t w ee k 4) . … systematically assessed observational studies and case reports of nonbenzodiazepine hypnotics. … certain sleep outcomes,54 achievement of sleep outcomes below specified value), it is not always clear how … Findings of safety in our review do not rule out the risk of serious adverse effects associated with

1260. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
      January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … intervention. 16-22 Overall, experts stated that current OA therapies treat only the symptoms and do … intervention. 40-46 Overall, experts stated that current therapies for OA treat only the symptoms and do … In general, the experts thought that tofacitinib would not shift how RA is treated or managed. … Experts all thought tofacitinib would have a large impact on costs, but diverged in how the impact